Roivant Sciences Ltd
Biotechnology
Healthcare
ROIV
707 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
14.95
52 week high
15.28
high
15.03
52 week low
0.00
previous Close
14.94
P/E ratio
market cap
7.44 B
div yield
0
net incoming
-206.48 M
-221.90 %
net profit margin
-2727.54 %
-4605.00 %
operating incoming
-284.97 M
-3.86 %
net change in cash
724 M
2.00 %
cash on hand
2.72 B
36.41 %
cost of revenue
205 K
-20.85 %
top